It was further shown that C8 was able to block the PD-L1/PD-1 interaction, activate T cells to a similar extent as an anti-PD-1 mAb, and could inhibit the growth of CT26 and B16 tumors, the latter being a known anti-PD-1 mAb resistant tumor model (220). This evidence concerns the gene CD274 and neoplasm.